Stomach Adenocarcinoma
Therapeutic response
Precision oncology relationships for therapeutic response involving this cancer type.
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| EMA (1) HSE (1) | HER2-negative, PD-L1 (CPS) >= 5 | Stomach Adenocarcinoma | Capecitabine, Nivolumab, Oxaliplatin | |
| EMA (1) HSE (1) | HER2-negative, PD-L1 (CPS) >= 5 | Stomach Adenocarcinoma | Fluorouracil, Nivolumab, Oxaliplatin |